{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,5]],"date-time":"2022-04-05T07:49:14Z","timestamp":1649144954707},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[1993,1,1]],"date-time":"1993-01-01T00:00:00Z","timestamp":725846400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancer Immunol Immunother"],"published-print":{"date-parts":[[1993,1]]},"DOI":"10.1007\/bf01516941","type":"journal-article","created":{"date-parts":[[2005,4,18]],"date-time":"2005-04-18T22:49:05Z","timestamp":1113864545000},"page":"47-53","source":"Crossref","is-referenced-by-count":4,"title":["Generation of cytotoxic T lymphocytes from peripheral blood of leukaemic patients"],"prefix":"10.1007","volume":"37","author":[{"given":"A. M. E.","family":"Nouri","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Dorey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C. L.","family":"Davis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Rohatiner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T. A.","family":"Lister","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R. T. D.","family":"Oliver","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"CR1","first-page":"206","volume":"48","author":"A Belldegrum","year":"1988","unstructured":"Belldegrum A, Muul LM, Rosenberg SA (1988) Interleukin-2 expanded tumour infiltrating lymphocytes in human renal cell cancer: isolation, characterization and antitumour activity. Cancer Res 48:206","journal-title":"Cancer Res"},{"key":"CR2","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1080\/00365516809168018","volume":"21","author":"Boyum","year":"1968","unstructured":"Boyum (1968) Separation of leukocytes from blood and bone marrow. Scan J Clin Lab Invest 21: 97","journal-title":"Scan J Clin Lab Invest"},{"key":"CR3","first-page":"1102","volume":"II","author":"AD Dayan","year":"1964","unstructured":"Dayan AD, Marshall AME (1964) Immunological reaction in man against certain tumours. Lancet II: 1102","journal-title":"Lancet"},{"key":"CR4","first-page":"964","volume":"51","author":"R Foa","year":"1991","unstructured":"Foa R, Guarini A, Tos AG, Cardona S, Fierro MT, et al. (1991) Peripheral blood and bone marrow immunophenotypic and functional modifications induced in acute leukemia patients treated with interleukin-2: evidence of in vivo lymphokine activated killer cell generation. Cancer Res 51: 964","journal-title":"Cancer Res"},{"key":"CR5","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1172\/JCI111201","volume":"73","author":"D Guerry","year":"1984","unstructured":"Guerry D, Alexander MA, Herlyn MF, et al. (1984) HLA-DR histocompatibility leukocyte antigens permit cultured human melanoma cells from early but not advanced discase to stimulate autologous lymphocytes. J Clin Invest 73: 267","journal-title":"J Clin Invest"},{"key":"CR6","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1038\/311750a0","volume":"311","author":"K Hui","year":"1984","unstructured":"Hui K, Grosveld F, Festenstein H (1984) Rejection of transplantable AKR leukaemia cells following MHC DNA-mediated transformation. Nature 311: 750","journal-title":"Nature"},{"key":"CR7","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1084\/jem.168.4.1419","volume":"168","author":"K Itoh","year":"1988","unstructured":"Itoh K, Platsoucas CD, Balch CM (1988) Autologous tumour specific cytotoxic T lymphocytes in the infiltrate of human metastatic melanomas: activation by interleukin-2 and autologous tumour cells, and involvement of the T cell receptor. J Exp Med 168: 1419","journal-title":"J Exp Med"},{"key":"CR8","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1084\/jem.147.3.912","volume":"147","author":"SK Lee","year":"1978","unstructured":"Lee SK, Oliver RTD (1978) Autologous leukaemia-specific T cell-mediated lymphocytotoxicity in patients with acute myelogenous leukaemia. J Exp Med 147: 912","journal-title":"J Exp Med"},{"key":"CR9","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1002\/ijc.2910370203","volume":"37","author":"F Momburg","year":"1986","unstructured":"Momburg F, Degener T, Bacchus E, Moldenhauer G, Hammerling GJ, Moller P (1986) Loss of HLA-A, B, C and de novo expression of HLA-D in colorectal cancer. Int J Cancer 37: 179","journal-title":"Int J Cancer"},{"key":"CR10","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1007\/BF00163578","volume":"10","author":"T Morita","year":"1992","unstructured":"Morita T, Salmeron MA, Moser RP, Ross MI, Itoh K (1992) Oligoclonal expansion of V?8+ cells in interleukin-2-activated T cells residing in subcutaneous metastatic melanoma. Clin Exp Metastasis 10: 69","journal-title":"Clin Exp Metastasis"},{"key":"CR11","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1038\/bjc.1990.338","volume":"62","author":"AME Nouri","year":"1990","unstructured":"Nouri AME, Smith MEF, Crosby D, Oliver RTD (1990) Selective and non-selective loss of immunoregulatory molecules (HLA-A, B, C antigens and LFA-3) in transitional cell carcinoma. Br J Cancer 62: 603","journal-title":"Br J Cancer"},{"key":"CR12","first-page":"1000","volume":"64","author":"AME Nouri","year":"1991","unstructured":"Nouri AME, Dos Santos AVL, Crosby D, Oliver RTD (1991) Correlation between class I antigen expression and ability to generate tumour infiltrating lymphocytes from bladder tumour biopsies. Br J Cancer 64: 1000","journal-title":"Br J Cancer"},{"key":"CR13","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1016\/0277-5379(91)90318-8","volume":"27","author":"RTD Oliver","year":"1991","unstructured":"Oliver RTD (1991) New views on rejection mechanisms and their relevance to interleukin-2 as a treatment for renal cell cancel. Eur J Cancer 27: 1168","journal-title":"Eur J Cancer"},{"key":"CR14","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1007\/978-3-642-67057-2_48","volume-title":"Modern trends in leukaemia","author":"RTD Oliver","year":"1979","unstructured":"Oliver RTD, Lee SK (1979) Histocompatibility antigens and T cell responses to leukaemia antigens. In: Reithmuller C (ed) Modern trends in leukaemia. Springer, Berlin Heidelberg New York p 377"},{"key":"CR15","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1111\/j.1464-410X.1972.tb10104.x","volume":"44","author":"A Pomerance","year":"1972","unstructured":"Pomerance A (1972) Pathology and progression following, total cystectomy for carcinoma of bladder. Br J Urol 44: 451","journal-title":"Br J Urol"},{"key":"CR16","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1126\/science.3489291","volume":"233","author":"SA Rosenberg","year":"1986","unstructured":"Rosenberg SA, Spiess P, Lafrenier R (1986) A new approach to the adoptive immunotherapy of cancer with tumour infiltrating lymphocytes. Science 233: 1318","journal-title":"Science"},{"key":"CR17","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1056\/NEJM198704093161501","volume":"316","author":"SA Rosenberg","year":"1987","unstructured":"Rosenberg SA, Lotze MT, Muule LM et al. (1987) A progress report on the treatment of 157 patients with advanced cancer using lymphokine-activated killer cells and interleukin-2 or high dose interleukin-2 alone. N Engl J Med 316: 889","journal-title":"N Engl J Med"},{"key":"CR18","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1056\/NEJM199008303230904","volume":"323","author":"SA Rosenberg","year":"1990","unstructured":"Rosenberg SA, Aebersold P, Cornetta K et al. (1990) Gene transfer into human-immunotherapy of patients with advanced melanoma, using tumour infiltrating lymphocytes modified by retroviral gene transduction. N Engl J Med 323: 570","journal-title":"N Engl J Med"},{"key":"CR19","doi-asserted-by":"crossref","first-page":"5557","DOI":"10.1073\/pnas.86.14.5557","volume":"86","author":"MEF Smith","year":"1989","unstructured":"Smith MEF, Marsh SGE, Bodmer JG, Gelsthorpe K, Bodmer WF (1989) Loss of HLA-A, B, C allele products and lymphocyte function-associated antigen 3 in colorectal neoplasia. Proc Natl Acad Sci USA 86: 5557","journal-title":"Proc Natl Acad Sci USA"},{"key":"CR20","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/S0022-1759(87)80018-2","volume":"102","author":"SL Topalian","year":"1987","unstructured":"Topalian SL, Muule LM, Solomon D, Rosenberg SA (1987) Expansion of human tumour infiltrating lymphocytes for use in immunotherapy trials. J Immunol Methods 102: 127","journal-title":"J Immunol Methods"},{"key":"CR21","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1200\/JCO.1988.6.5.839","volume":"6","author":"SL Topalian","year":"1988","unstructured":"Topalian SL, Solomon D, Avis FP, Chang AE, Freerksen DL, Linehan WM, Lotze MT, Robertson CN, Seipp CA, Simon P, Simpson CG, Rosenberg SA (1988) Immunotherapy of patients with advanced cancer using tumour infiltrating lymphocytes and recombinant interleukin-2; a pilot study. J Clin Oncol 6: 839","journal-title":"J Clin Oncol"},{"key":"CR22","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1159\/000281440","volume":"44","author":"H Tsujihashi","year":"1989","unstructured":"Tsujihashi H, Uejima S, Akiyama T, Kurita T (1989) Immunohistochemical detection of tissue infiltrating lymphocytes in bladder tumours. Urol Int 44: 5","journal-title":"Urol Int"},{"key":"CR23","first-page":"1341","volume":"46","author":"TL Whiteside","year":"1987","unstructured":"Whiteside TL, Heo S, Adler A, et al. (1987) Expansion of tumour infiltrating lymphocytes from human solid tumours in interleukin-2. Fed Proc 46: 1341","journal-title":"Fed Proc"}],"container-title":["Cancer Immunology Immunotherapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF01516941\/fulltext.html","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF01516941.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF01516941\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF01516941","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,3]],"date-time":"2019-05-03T12:55:19Z","timestamp":1556888119000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF01516941"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1993,1]]},"references-count":23,"journal-issue":{"issue":"1","published-print":{"date-parts":[[1993,1]]}},"alternative-id":["BF01516941"],"URL":"https:\/\/doi.org\/10.1007\/bf01516941","relation":{},"ISSN":["0340-7004","1432-0851"],"issn-type":[{"value":"0340-7004","type":"print"},{"value":"1432-0851","type":"electronic"}],"subject":[],"published":{"date-parts":[[1993,1]]}}}